People who drink any type of coffee, caffeinated or not, are less likely to develop or die from chronic liver disease than those who don’t drink the beverage, a UK study shows.

Compared to non-coffee drinkers, coffee drinkers had a 21% reduced risk of chronic liver disease, a 20% reduced risk of chronic liver disease or steatosis, a 20% reduced risk of hepatocellular carcinoma and a 49% reduced risk of death from chronic liver disease.

Researchers at the universities of Southampton and Edinburgh examined data on 384,818 participants in the UK Biobank study who reported coffee consumption and 109,767 who didn’t drink coffee.

After a median follow-up period of 10.7 years, researchers identified 3,600 cases of chronic liver disease, 5,439 cases of chronic liver disease or steatosis, 184 cases of hepatocellular carcinoma, and 301 deaths from chronic liver disease.